| Trial ID: | L0196 |
| Source ID: | NCT00888290
|
| Associated Drug: |
Sodium Bicarbonate
|
| Title: |
Sodium Bicarbonate Supplementation in Chronic Kidney Disease Evaluation of Dose Response, Safety and Beneficial Effects
|
| Acronym: |
|
| Status: |
COMPLETED
|
| Study Results: |
YES
|
| Results: |
https://ClinicalTrials.gov/show/NCT00888290/results
|
| Conditions: |
Chronic Kidney Disease
|
| Interventions: |
DRUG: Sodium bicarbonate|DRUG: Placebos
|
| Outcome Measures: |
Primary: Serum Bicarbonate Levels, 8 weeks | Secondary: Muscle Strength as Measured by sit-to Stand Test, 10 repetition sit-to-stand test, 8 weeks|Systolic Blood Pressure, 8 weeks
|
| Sponsor/Collaborators: |
Sponsor: Albert Einstein College of Medicine
|
| Gender: |
ALL
|
| Age: |
ADULT, OLDER_ADULT
|
| Phases: |
PHASE2|PHASE3
|
| Enrollment: |
20
|
| Study Type: |
INTERVENTIONAL
|
| Study Designs: |
Allocation: NON_RANDOMIZED|Intervention Model: SEQUENTIAL|Masking: SINGLE (PARTICIPANT)|Primary Purpose: TREATMENT
|
| Start Date: |
2009-03
|
| Completion Date: |
2010-05
|
| Results First Posted: |
2022-08-30
|
| Last Update Posted: |
2022-08-30
|
| Locations: |
Albert Einstein College of Medicine/ Montefiore Medical Center, Bronx, New York, 10461, United States
|
| URL: |
https://clinicaltrials.gov/show/NCT00888290
|
